How much does a box of erdafitinib cost in the country?

Erdafitinib (Erdafitinib) is a new type of targeted therapy mainly used to treat adult patients with locally advanced or metastatic urothelial carcinoma (mUC; bladder cancer ), especially those with susceptibilityFGFR3 gene alterations. Such patients often still experience disease progression after at least one systemic treatment, and therefore are in urgent need of effective treatment options. Erdafitinib can effectively slow down the growth and spread of tumor cells and improve patients' survival rate and quality of life by inhibiting the FGFR signaling pathway.

In China, erdafitinib has been approved for marketing under the trade name BALVERSA. Common specifications include 5mg 28 tablets, 3mg 56 tablets and 4mg*28 tablets. However, because the drug has not yet been included in the national medical insurance, its price is relatively high, which puts financial pressure on patients. Currently, the domestic selling price of erdafitinib is approximately RMB 10,000 per box. The specific price may vary depending on regions and sales channels.

Since erdafitinib has not been on the market for a long time, patients may face certain difficulties when purchasing the drug directly in China. This has led some patients to choose to purchase erdafitinib through foreign channels. In the Hong Kong market, the original drugs of erdafitinib mainly include the Hong Kong version of the original drugs, which are priced as high as more than 20,000 yuan and usually need to be purchased through specific pharmacies. In addition, patients can also consider foreign generic drugs, such as the Laos version and the Bangladeshi Yaopin International version. These drugs are relatively cheap, with prices ranging from a few hundred yuan to more than 2,000 yuan, and their drug ingredients are usually basically the same as the original drugs.

Before using erdafitinib, patients need to undergo genetic testing to confirm whether they are suitable for this targeted therapy. Doctors will develop an individualized treatment plan based on the patient's specific conditions and conduct regular follow-up visits during treatment to monitor efficacy and side effects.

Reference materials：https://www.balversa.com/